HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Bartalena Selected Research

Graves Ophthalmopathy

11/2022Current concepts regarding Graves' orbitopathy.
1/2022Management of Graves' hyperthyroidism: present and future.
11/2021Statins for Graves' orbitopathy: a new tool for prevention and treatment?
11/2019Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?
1/2018Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
9/2014Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy?
11/2012Efficacy and safety of orbital radiotherapy for graves' orbitopathy.
2/2012Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association.
5/2011Selenium and the course of mild Graves' orbitopathy.
8/2010What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Bartalena Research Topics

Disease

28Graves Ophthalmopathy
11/2022 - 03/2002
22Hyperthyroidism
11/2022 - 10/2002
22Thyrotoxicosis
10/2021 - 01/2002
12Hypothyroidism
11/2022 - 10/2002
12Graves Disease (Basedow Disease)
11/2022 - 10/2002
8Thyroiditis
03/2018 - 05/2003
7Acromegaly
06/2009 - 05/2002
4Thyroid Diseases (Thyroid Disease)
01/2018 - 05/2003
3Strabismus (Squint)
03/2016 - 12/2013
3Thyroid Neoplasms (Thyroid Cancer)
07/2007 - 02/2006
3Colonic Polyps
07/2004 - 05/2002
2Primary Hyperparathyroidism
06/2020 - 03/2004
2Hyperplasia
01/2020 - 08/2018
2Hypertension (High Blood Pressure)
11/2017 - 08/2003
2Exophthalmos (Proptosis)
12/2013 - 03/2002
2Neoplasms (Cancer)
04/2011 - 03/2002
2Adenocarcinoma
10/2009 - 12/2005
2Polyps
06/2009 - 08/2003
2Pituitary Neoplasms (Pituitary Adenoma)
10/2006 - 06/2004
2Carcinogenesis
12/2005 - 08/2003
2Colonic Neoplasms (Colon Cancer)
07/2004 - 08/2003
2Eye Diseases (Eye Disease)
10/2002 - 04/2002
1Pancreatitis
12/2020
1Bone Diseases (Bone Disease)
06/2020
1Hypercalcemia (Milk Alkali Syndrome)
06/2020
1Goiter
01/2020
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
01/2018
1Type 2 Diabetes Mellitus (MODY)
11/2017
1Obesity
11/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2017
1Abdominal Obesity
11/2017
1Hyperglycemia
11/2017
1Retinal Perforations
03/2017
1Retinal Diseases
12/2013
1Hypertrophy
12/2013
1Myocardial Infarction
10/2012
1Left Ventricular Dysfunction
10/2012

Drug/Important Bio-Agent (IBA)

21Amiodarone (Amiodarona)FDA LinkGeneric
10/2021 - 01/2002
16GlucocorticoidsIBA
11/2022 - 05/2003
13IodineIBA
11/2022 - 10/2004
11Thyroid HormonesIBA
01/2022 - 10/2002
7Antithyroid Agents (Antithyroid Drugs)IBA
11/2022 - 10/2002
6AntibodiesIBA
01/2022 - 06/2007
6PPAR gammaIBA
01/2007 - 05/2002
5Rituximab (Mabthera)FDA Link
11/2022 - 05/2008
5Methimazole (Thiamazole)FDA LinkGeneric
01/2022 - 10/2002
5Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2022 - 12/2013
5Thyroxine (Levothyroxine)FDA LinkGeneric
01/2020 - 10/2002
4Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
10/2021 - 10/2002
4Biological ProductsIBA
11/2019 - 05/2008
4Pharmaceutical PreparationsIBA
08/2018 - 12/2002
4Growth Hormone (Somatotropin)IBA
10/2009 - 03/2004
4Insulin-Like Growth Factor I (IGF-1)IBA
04/2006 - 05/2002
3SeleniumIBA
01/2022 - 05/2011
3Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2020 - 10/2002
3CytokinesIBA
05/2011 - 04/2002
3Immunomodulating AgentsIBA
03/2010 - 05/2008
3LithiumIBA
01/2010 - 10/2002
2thyrotropin-binding inhibitory immunoglobulinIBA
11/2022 - 10/2002
2Vitamin DFDA LinkGeneric
01/2022 - 11/2017
2Long-Acting Thyroid Stimulator (LATS)IBA
10/2021 - 10/2006
2AntigensIBA
08/2018 - 04/2002
2Iodide Peroxidase (Deiodinase)IBA
01/2018 - 12/2002
2Prednisone (Sone)FDA LinkGeneric
11/2011 - 03/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 05/2008
2Hormones (Hormone)IBA
07/2007 - 06/2007
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2004 - 07/2002
2Iopanoic Acid (Telepaque)FDA Link
05/2003 - 12/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2022
1Azathioprine (Imuran)FDA LinkGeneric
11/2022
1teprotumumabIBA
11/2022
1Cholecalciferol (Vitamin D3)FDA Link
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2021
1DenosumabFDA Link
06/2020
1Parathyroid Hormone (Parathormone)IBA
06/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Troleandomycin (TAO)FDA Link
11/2019
1AutoantibodiesIBA
08/2018
1Immunoglobulins (Immunoglobulin)IBA
06/2018
1MethylprednisoloneFDA LinkGeneric
01/2018
1TabletsIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
11/2017
1hydroxide ionIBA
11/2017
1Retinaldehyde (Retinal)IBA
03/2017
1SteroidsIBA
10/2014
1Etanercept (Enbrel)FDA Link
09/2014
1tocilizumab (atlizumab)FDA Link
09/2014
1Adalimumab (Humira)FDA Link
09/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013
1Warfarin (Coumadin)FDA LinkGeneric
11/2013
1AntioxidantsIBA
05/2011
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2011
1Oxygen (Dioxygen)IBA
05/2011
1Free RadicalsIBA
05/2011

Therapy/Procedure

22Therapeutics
10/2021 - 10/2002
15Thyroidectomy
11/2022 - 10/2002
8Radiotherapy
11/2022 - 03/2002
5Decompression
03/2016 - 08/2005
2Parathyroidectomy
06/2020 - 03/2004
2Secondary Prevention
10/2002 - 04/2002